RedHill Biopharma Sells Stomach Treatment Stake for 18 Million Dollars

Raleigh, Monday, 31 August 2026.
On August 31, 2026, RedHill Biopharma secured $18 million in upfront cash by selling its 70% stake in Talicia to Apotex, providing vital liquidity to fund new acquisitions.